SHE:002821 - Asymchem Laboratories Tianjin Co Ltd

Asymchem Laboratories Tian Jin
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2011 Q4	2012 Q4	2013 Q4	2014 Q4	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.64B 5.6%	3.99B 9.5%	4.64B 16.3%	5.92B 27.7%	7.92B 33.7%	9.53B 20.3%	10.26B 7.6%	10.44B 1.8%	9.84B -5.8%	8.83B -10.3%	7.83B -11.3%	6.98B -10.9%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2B 6.6%	2.22B 10.8%	2.58B 16.4%	3.27B 26.5%	4.28B 31.1%	5.12B 19.5%	5.4B 5.4%	5.43B 0.6%	4.9B -9.8%	4.18B -14.6%	3.82B -8.6%	3.45B -9.7%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.64B 4.4%	1.77B 7.9%	2.06B 16.1%	2.66B 29.2%	3.64B 36.9%	4.41B 21.2%	4.86B 10.2%	5.01B 3.2%	4.94B -1.5%	4.65B -5.9%	4B -13.9%	3.52B -12.0%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.67B 6.1%	2.96B 10.8%	3.46B 17.1%	4.28B 23.7%	5.48B 28.0%	6.51B 18.7%	7.08B 8.8%	7.15B 1.0%	6.68B -6.6%	6.02B -9.9%	5.53B -8.2%	5.22B -5.7%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	666.09M 4.5%	737.47M 10.7%	880.75M 19.4%	1.02B 15.5%	1.2B 18.1%	1.39B 16.0%	1.69B 20.9%	1.72B 2.2%	1.79B 3.7%	1.84B 3.2%	1.71B -7.3%	1.77B 3.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	975.04M 4.3%	1.03B 6.0%	1.18B 13.8%	1.64B 39.4%	2.44B 48.6%	3.01B 23.8%	3.17B 5.2%	3.29B 3.7%	3.15B -4.2%	2.8B -11.1%	2.3B -18.1%	1.76B -23.4%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	835.77M -	-	1.07B -	-	2.38B -	-	3.29B -	-	3.24B -	-	2.25B -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	835.81M 8.8%	910.72M 9.0%	1.07B 17.4%	1.41B 32.3%	2.38B 68.3%	3.1B 30.1%	3.3B 6.7%	3.43B 4.0%	3.25B -5.4%	2.79B -14.1%	2.27B -18.7%	1.92B -15.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.5 7.0%	2.7 8.0%	3.143 16.4%	4.05 28.9%	6.986 72.5%	7.723 10.6%	9.02 16.8%	9.38 4.0%	8.92 -4.9%	7.66 -14.1%	6.26 -18.3%	5.3 -15.3%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.493 7.4%	2.686 7.7%	3.136 16.8%	4.036 28.7%	6.976 72.8%	7.696 10.3%	9 16.9%	9.36 4.0%	8.91 -4.8%	7.66 -14.0%	6.26 -18.3%	5.3 -15.3%